These results suggest that the miR-29b/PMP22 axis may serve as a novel potential therapeutic target against EV71-induced neuronal disorder in severe HFMD cases and provide evidence that circRNAs may be involved in the process. This evidence concerns the gene PMP22 and hand, foot and mouth disease.